Anna Schuh, MD, PhD, from the University of Oxford, UK, gives an overview of her talk on the advances in…
Andrew Zelenetz, MD, PhD, from Memorial Sloan-Kettering Cancer Center, New York, NY gives an overview of the case studies on…
In this Ask the Expert video segment, multiple myeloma expert Dr. Jatin Shah of MD Anderson Cancer Center responds to…
With all of the advances in cancer research, where does the field of prostate cancer stand? Andrew Schorr, Patient Power…
This was my talk at the University of Minnesota’s Masonic Cancer Center Seminar Series on May 10, 2016. I review…
Ruben Mesa, MD, from the Mayo Clinic, Scottsdale, AZ, USA discusses current developments in myeloproliferative neoplasms (MPNs) at the 2016…
Ruben Mesa, MD, from the Mayo Clinic, Scottsdale, AZ, USA discusses how to manage adult myeloproliferative neoplasm (MPN) patients at…
Ruben Mesa, MD, from the Mayo Clinic, Scottsdale, AZ, USA provides an overview of his talk on individualizing care for…
Peter Hillmen, MD, PhD, from St. James’ University Hospital, Leeds, UK gives an overview of the RESONATE-2 trial (NCT01722487), a…
Nigel Russell, MD, from Nottingham University Hospitals NHS Trust, Nottingham, UK discusses the potential benefit of a higher dose of…
Gilles Salles, MD, PhD, from South Lyon Hospital Complex, Lyon, France discusses the management of patients with follicular lymphoma in…
Nigel Russell, MD, from Nottingham University Hospitals NHS Trust, Nottingham, UK talks about new and emerging drug targets in acute…
Gilles Salles, MD, PhD, from South Lyon Hospital Complex, Lyon, France provides an overview of his presentation on ‘chemo-free’ in…
Thomas Martin, MD, from the UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, discusses the tolerability of monoclonal…
Thomas Martin, MD, from the UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, discusses the use of monoclonal…
Lawrence Boise, PhD, from the Winship Cancer Institute, Atlanta, GA, discusses the use and side effects of venetoclax for multiple…
Lawrence Boise, PhD, from the Winship Cancer Institute, Atlanta, GA discusses the possibility of exploiting the biology of the plasma…
Faith Davies, MBBCh, MRCP, MD, FRCPath from UAMS Myeloma Institute, Arkansas, AZ discusses the importance of the microenvironemt in multiple…
Antonio Palumbo, MD, from the University of Turin, Turin, Italy, provides an overview of his talk on ‘Perspectives on future…
At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 1316 April 2016, Joseph Paul Eder, MD,…
At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 1316 April 2016, Martin Reck, MD, PhD,…
At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 1316 April 2016, Niki Karachaliou, MD, from…
Pages Image Alignment
At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 1316 April 2016, Enriqueta Felip, MD, PhD,…
At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 1316 April 2016, Giorgio Scagliotti, MD, PhD,…
At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 1316 April 2016, David Carbone, MD, PhD,…
At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 1316 April 2016, Kenneth O’Byrne, MD, from…
At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 1316 April 2016, Giorgio Scagliotti, MD, PhD,…
At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 1316 April 2016, Enriqueta Felip, MD, PhD,…
At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 1316 April 2016, Kenneth O’Byrne, MD, from…
At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 1316 April 2016, David Carbone, MD, PhD,…
Faith Davies, MBBCh, MRCP, MD, FRCPath from UAMS Myeloma Institute, Arkansas, AZ gives an update on the use of trametinib,…
Bruno Paiva, PhD, from the University of Navarra, Pamplona, Spain discusses the various features of multiple myeloma (MM) that make…
Arnon Nagler, MD, from Sheba Medical Center, Tel Hashomer, Israel, gives an overview of matched unrelated donor (MUD) transplantation for…
At the 2016 Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain, Antonio…
Ann Leen, PhD, from Baylor College of Medicine, Houston, TX, US, provides an overview of the ‘off the shelf’ use…
Niels van de Donk, MD, PhD, from the University Medical Center, Amsterdam, Netherlands discusses the use and mechanism of action…
Marta Chesi, PhD, from the Mayo Clinic, Scottsdale, AZ discusses LCL-1 for the treatment of multiple myeloma (MM). LCL-1 has…
At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 1316 April 2016, Giorgio Scagliotti, MD, PhD,…
At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 1316 April 2016, Keith Kerr, BSc, MB…
At the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain, John…
At the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation, held in Valencia, Spain, Jane Apperley,…
Giovanni Martinelli, MD, from the University of Bologna, Bologna, Italy discusses the success of targeted drugs such inotuzumab ozogamicin in…
At the 2016 Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain, Antonio…
At the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation, held in Valencia, Spain, Jane Apperley,…
Giovanni Martinelli, MD, from the University of Bologna, Bologna, Italy discusses how inotuzumab ozogamicin is now used as a frontline…
At the 2016 Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain, Antonio…
At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 1316 April 2016, Zoran Gatalica, MD, DSc,…
The Myeloma 2016 meeting, was held in Boston, MA, between 2224 April. Keith Stewart MB, ChB from the Mayo Clinic,…
At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 1316 April 2016, Joseph Paul Eder, MD,…
At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 1316 April 2016, Niki Karachaliou, MD, from…
Michael P Kosty, MD, FACP, FASCO Medical Director, Scripps Green Cancer Center gives an update on Immunotherapy of Lung Cancer
Dr. Richard Essner, M.D., F.A.C.S. Cedar Sinai Cancer Center Surgical Director, Melanoma Program discusses the New Role of Surgery in…
Dr.Michael Alvarado, MD and Dr. Rick Baehner, MD present case studies and a presentation on Genomic Update in Hormone Receptor…
Dr. Daniel S. Oh, MD Assistant Professor of Surgery Division of Thoracic Surgery Keck Medical Center of USC discusses how…
Dr. Jorge J. Nieva, MD Associate Professor of Clinical Medicine University of Southern California discusses a study conducted by Memorial…
Dr. Samuel J. Klempner, MD Director of Precision Medicine The Angeles Clinic and Research Institute discusses how Diagnostic Dilemmas and…
Dr. Omid Hamid MD of the Chief, Translational Research & Immuno-Oncology Director, Cutaneous Malignancies, The Angeles Clinic and Research Institute discusses…
Sybil R. Green, JD, RPh, MHA ACC, LOS, MOS from ASCO discusses how the updated government program called MACRA will…
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Fatima…
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Jan-Willem…
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Fatima…
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Jeremy…
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Andrew…
At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 1316 April 2016, Martin Reck, MD, PhD,…
Dr. John Gribben, University of London, and Dr. Constantine Tam, Peter MacCallum Cancer Centre, join Patient Power Founder, Andrew Schorr,…
The session was held in collaboration with EONS (European Oncology Nursing Society) and discussed the management of skin reactions due…
This session was held in collaboration with EONS (the European Oncology Nursing Society) and explores treatments options in case of…
This session was held in collaboration with EONS (European Oncology Nursing Society) and covers the specific difficulties health care professionals…
At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 1316 April 2016, Enriqueta Felip, MD, PhD,…
Is there a positive correlation between the use of a JAK Inhibitor and stem cell transplant (SCT)? UK viewer, Peter,…
Toxicity as a Biomarker Frede Donkosov MD
At the 2016 Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain, Antonio…
At the 2016 Annual Meeting of the Europea n Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain,…
At the 2016 Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain, Antonio…
At the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation, held in Valencia, Spain, John Gribben,…
Mohamad Mohty, MD, PhD, from Saint-Antoine Hospital, Paris, France, and President of the European Society for Blood and Marrow Transplantation…
At the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain, John…
At the 2016 Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain, Catherine…
At the 2016 Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain, Antonio…
Ann Leen, PhD, from Baylor College of Medicine, Houston, TX, US, provides an overview of virus-specific T cells from how…
At the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain, John…
At the 2016 Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain, Gesine…
Where do we stand in understanding and diagnosing prostate cancer? Patient Power founder, Andrew Schorr, visits with renowned expert Dr.…
Patient Power Founder and host, Andrew Schorr interviews CLL expert Dr. Richard Furman to discuss the evolving CLL treatment landscape,…
What new identifying factors are making a difference for lung cancer patients? Patient Power founder Andrew Schorr interviewed lung cancer…
Andrew Schorr asks lung cancer expert Dr. Rebecca Heist of Harvard Medical School to discuss the advances made in brain…
At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 1316 April 2016, Kenneth O’Byrne, MD, from…
At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 1316 April 2016, David Carbone, MD, PhD,…
Roy Chemaly, MD, from the University of Texas MD Anderson Cancer Center, Houston, TX, USA, discusses the importance about educating…
Roy Chemaly, MD, from the University of Texas MD Anderson Cancer Center, Houston, TX, USA, provides an overview of a…
At the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation, held in Valencia, Spain, John Gribben,…
At the 2016 Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain, Gesine…
At the 2016 Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain, Arno…
At the 6th European Lung Cancer Conference (ELCC), held in Geneva, Switzerland, from 1316 April 2016, Don Gibbons, MD, PhD,…
Giovanni Martinelli, MD, from the University of Bologna, Bologna, Italy discusses the side-effects of inotuzumab ozogamicin, which targets CD22 in…
At the 2016 Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain, Gesine…
At the 2016 Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain, Arno…
Roy Chemaly, MD, from the University of Texas MD Anderson Cancer Center, Houston, TX, USA, discusses the T-SPOT.TB assay for…
Chiara Bonini, MD, from San Raffaele Scientific Institute, Milano, Italy, gives an overview of the progress that has been made…
Bruno Paiva, PhD, from the University of Navarra, Pamplona, Spain, gives an overview of his talk on whether or not…
At the 2016 Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain, Arno…
At the 2016 Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain, Arno…
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Andrew…
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Isabel…
The bone marrow biopsy is used to diagnose and manage the treatment of a range of blood cancers. Here, John…
David Marks, MD, PhD, from the University Hospitals Bristol NHS Foundation Trust, Bristol, UK, provides an overview of the randomized…
Roy Chemaly, MD, from the University of Texas MD Anderson Cancer Center, Houston, TX, USA, provides an overview of an…
Giovanni Martinelli, MD, from the University of Bologna, Bologna, Italy talks about blinatumomab for the treatment of acute lymphoblastic leukemia…
At the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain, EBMT…
At the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation, held in Valencia, Spain, Navneet Majhail,…
At the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain, EBMT…
At the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain, EBMT…
At the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain, Mike…
At the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation, held in Valencia, Spain, Miguel Perales,…
At the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain, Catherine…
At the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation, held in Valencia, Spain, Arnon Nagler,…
At the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), held in Valencia, Spain, Paul…
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Giuseppe…
Mohamad Mohty, MD, PhD, from Saint-Antoine Hospital, Paris, France and President of the European Society for Blood and Marrow Transplantation…
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Douglas…
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Fatima…
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Isabel…
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Giuseppe…
How much progress has been made in the field of lung cancer? Can patients expect increased treatment options? Patient Power…
Viewer Cindy in this Ask the Expert segment asks MPN expert Dr. Naval Daver, Can the effectiveness of ruxolitinib (Jakafi)…
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Andrew…
B.J. Rimel, MD of Cedars Sinai Medical Center discusses the SGO 2016 highlights and trends from SGO 2016. Transcription: I…
B.J. Rimel, MD of Cedars Sinai Medical Center discusses the next 5 years in gynaecologic malignancies treatment from SGO 2016.…
B.J. Rimel, MD of Cedars Sinai Medical Center discusses the SGO Presidential address and how inspirational it was from SGO…
B.J. Rimel, MD of Cedars Sinai Medical Center discusses the high number of uterine and BRCA mutations from study focusing…
B.J. Rimel, MD of Cedars Sinai Medical Center discusses the future clinical trials in ovarian cancer from SGO 2016. Transcription:…
Karen H. Lu, MD of MD Anderson discusses recommendations to physicians whos patients are concerned about their risk of ovarian…
Karen H. Lu, MD of MD Anderson discusses how genetic testing improves early detection of BRCA in at risk women…
Karen H. Lu, MD of MD Anderson discusses genomic analysis and prophylactic surgical management for women with inherited genetic abnormalities…
Karen H. Lu, MD of MD Anderson discusses genetic counseling and prophylactic measures for women at high risk for ovarian…
Karen H. Lu, MD of MD Anderson says that all women with ovarian cancer should undergo genomic testing for BRCA…
Thomas Herzog, MD of UC Health discusses preoperative staging and likelihood of R0 resection in gynecologic cancer at SGO 2016.
Thomas Herzog, MD of UC Health discusses neoadjuvant regimen for patients with ovarian cancer at SGO 2016.
Thomas Herzog, MD of UC Health discusses GOG-172 and the ability to modify the Armstrong regimen for greater tolerability at…
Thomas Herzog, MD of UC Health discusses neoadjuvant chemotherapy compromise postoperative recovery at SGO 2016.
Thomas Herzog, MD of UC Health discusses age and the decision to use intraperitoneal chemotherapy in ovarian cancer at SGO…
Martee L. Hensley, MD of Memorial Sloan Kettering discusses how trabectedin improves PFS over Dacarbazine in uterine leiomyosarcoma at SGO…
Martee L. Hensley, MD of Memorial Sloan Kettering discusses trabectedin improves patients with drug resistant metastatic leiomyosarcoma at SGO 2016.
Martee L. Hensley, MD of Memorial Sloan Kettering discusses gynecologic cancer treatment trends at SGO 2016.
Martee L. Hensley, MD of Memorial Sloan Kettering discusses GOG-86P results and genetic testing among most notable data released at…
Martee L. Hensley, MD of Memorial Sloan Kettering discusses genomic analysis and immunotherapy are treatments to watch in gynecologic malignancies…
Michael J. Birrer, MD of Massachusetts General Hospital discusses toxicities of anti-PD-1 and anti-PD-L1 in gynecologic cancers at SGO 2016.…
Michael J. Birrer, MD of Massachusetts General Hospital discusses the unique side effects of trabectedin at SGO 2016. Transcription: The…
Michael J. Birrer, MD of Massachusetts General Hospital discusses promising immunotherapy currently under evaluation for advance gynecologic cancers at SGO…
Is there a reliable test to determine whether a patient has a tendency to develop blood clots? Andrew Schorr asks…
Michael J. Birrer, MD of Massachusetts General Hospital discusses PDL-1 and immune checkpoint inhibitors in endometrial cancer at SGO 2016.…
The international Consensus Conference for Advanced Breast Cancer (ABC) has established itself as a major international breast cancer conference. Its…
Michael J. Birrer, MD of Massachusetts General Hospital discusses ovarian cancer is targetable with PARP inhibitors at SGO 2016. Transcription:…
Michael J. Birrer, MD of Massachusetts General Hospital discusses multiplex testing and next generation sequencing in metastatic ovarian cancer at…
Michael J. Birrer, MD of Massachusetts General Hospital discusses mirvetuximab soravtansin side effects compared to other systemic treatments in heavily…
Michael J. Birrer, MD of Massachusetts General Hospital discusses HPV-related cervical cancer with anti-PD-1 and anti-PDL-1 antibodies at SGO 2016.…
Michael J. Birrer, MD of Massachusetts General Hospital discusses guidelines for micro satellite instability or MSI testing for endometrial patients…
Michael J. Birrer, MD of Massachusetts General Hospital discusses current actionable mutations in advanced ovarian cancer at SGO 2016. Transcription:…
Elizabeth Swisher MD of the University Of Washington discusses Vice President Bidens initiative to increase clinical trials for women with…
Elizabeth Swisher MD of the University Of Washington discusses using Next Generation Genetic Sequencing to determine what fraction of ovarian…
Elizabeth Swisher MD of the University Of Washington discusses ovarian cancer focus for 2016 to include genetic analysis and target…
Elizabeth Swisher MD of the University Of Washington discusses how genomic analysis will strengthen prophylactic surgical management in inherited genetic…
Elizabeth Swisher MD of the University Of Washington discusses how genomic analysis may improve prevention, screening and management of inherited…
Elizabeth Swisher MD of the University Of Washington discusses the clinical factors for requesting a genomic analysis for at risk…
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Giuseppe…
Triple-negative breast cancer (TNBC) represents a biologically and clinically heterogeneous disease. At the 10th European Breast Cancer Conference (EBCC), held…
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Fatima…
At the German Cancer Congress 2016, held in Berlin, Germany from 24 to 27 February 2016, Viktor Grünwald, MD, PhD,…
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Martin Reck, MD, PhD,…
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Matthias Löhr, MD, PhD,…
At the German Cancer Congress 2016, held in Berlin, Germany from 24 to 27 February 2016, Viktor Grünwald, MD, PhD,…
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Martin Reck, MD, PhD,…
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Matthias Löhr, MD, PhD,…
Why are researchers and physicians so excited about combination CLL therapy? Patient Power Founder Andrew Schorr sits down with CLL…
In this Ask the Expert segment, MPN expert Dr. Naval Daver of MD Anderson Cancer Center explains why the current…
Why are researchers and physicians so excited about combination CLL therapy? Patient Power Founder Andrew Schorr sits down with CLL…
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Christoph Röllig, MD, from…
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Wolfgang Hiddemann, MD, PhD,…
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Christoph Röllig, MD, from…
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Michael Hallek, MD, from…
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Michael Hallek, MD, from…
Immunotherapy is personalized therapy for people with cancer–but can it outsmart CLL? Experts Drs. John Gribben, Constantine Tam,and William Wierda,…
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Michael Hallek, MD, from…
Dr. Toni Choueiri of the Dana Farber Cancer Institute discusses the subgroup analyses of METEOR, a randomized phase 3 trial…
Tony Choueiri, MD of Dana Farber discusses CheckMate 025 phase III trial at ASCO GU 2016
Robert Dreicer, MD of the University of Virginia Health System discusses immunotherapy in non muscle invasive bladder cancer at ASCO…
Robert Dreicer, MD of the University of Virginia Health System discusses the how soon should we expect approval of immunotherapy…
Robert Dreicer, MD of the University of Virginia Health System discusses the future role of immunotherapy and checkpoint inhibitors in…
Robert Dreicer, MD of the University of Virginia Health System discusses how Atezolizumab shows very significant activity in advanced urothelial…
Jeremy Abramson, MD, from the Massachusetts General Hospital, Massachusetts, MA, gives an overview of the interim analysis of a multicenter…
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Christof Scheid, MD, PhD,…
Monoclonal antibodies have been recognised for their significant potential in the treatment of multiple myeloma. At the German Cancer Congress…
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Dirk Reinhardt, MD, PhD,…
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Lorenz Trümper, MD, from…
Pediatric acute lymphoblastic leukemia (ALL) is a heterogeneous disease. At the German Cancer Congress 2016, held in Berlin, Germany, from…
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Lorenz Trümper, MD, from…
Progress in the field of blood cancers has resulted in the rapid development of more effective, less toxic therapies. At…
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Rüdiger Hehlmann, MD, from…
At the German Cancer Congress 2016, held in Berlin, Germany from 24 February to 27 February 2016, Axel Hauschild, MD,…
What are monoclonal antibodies, and how are they used to treat CLL? From MD Anderson Cancer Center, Drs. Zeev Estrov…
Understanding all of the emerging immunotherapy options for CLL patients can be difficult. Drs. Zeev Estrov, Michael Keating, and Nicole…
Are you refractory to some of the existing myeloma medications? Are you a relapsed patient? Myeloma experts Drs. John Burke,…
Understanding all of the emerging immunotherapy options for CLL patients can be difficult. Drs. Zeev Estrov, Michael Keating, and Nicole…
Guillermo De Velasco, MD at Dana Farber discusses discontinuing VEGF-TT for progression versus toxicity impacts outcomes of second-line therapies in…
Dr. Petros Grivas, MD at Cleveland Clinic discusses how genomics in urothelial carcinomas may play much bigger role in the…
Dr. Petros Grivas, MD at Cleveland Clinic discusses inhibiting autophagy in bladder cancer at ASCO GU 2016
Dr. Petros Grivas, MD at Cleveland Clinic discusses clinical and pathological factors that can influence outcomes in upper tract urothelial…
Dr. Petros Grivas, MD at Cleveland Clinic discusses if treatment for prior cancer develops secondary bladder cancer at ASCO GU…
Marin Xavier, MD of the Scripps Health discusses the greatest impact of immune checkpoint inhibitors in hematologic malignancies at Scripps…
Marin Xavier, MD of the Scripps Health discusses the management of hematologic and solid tumor malignancies with PD-1 and PD-L1…
Marin Xavier, MD of the Scripps Health discusses the most common adverse events for PD-1 and PD-L1 monoclonal antibodies at…
Marin Xavier, MD of the Scripps Heal;th discusses her real world experience with the novel immune checkpoint inhibitors at Scripps…
At the German Cancer Congress 2016, held in Berlin, Germany from 24 February to 27 February 2016, Axel Hauschild, MD,…
Josep-Maria Ribera, MD, PhD from the Germans Trias i Pujol University Hospital, Barcelona, Spain, presents preliminary data, which shows that…
Tanguy Seiwert, MD of the University of Chicago discusses using biomarkers in Immunotherapy in Head and Neck Cancer at Scripps…
Tanguy Seiwert, MD of the University of Chicago discusses Pembrolizumab and nivolumab Immunotherapies and that they Show Efficacy in Head…
Tanguy Seiwert, MD of the University of Chicago discusses Immunotherapy and how it is well tolerated in Head and Neck…
Tanguy Seiwert, MD of the University of Chicago discusses immunotherapy and future use of combination treatment in Head and Neck…
Susan M. O’Brien, MD of University of California Irvine discusses Venetoclax in the management of CLL and where in the…
Susan M. O’Brien , MD of University of California Irvine the preferred treatment regimen for patients who fail frontline therapy…
Susan M. O’Brien, MD of University of California Irvine the preferred salvage regimens for Ibrutinib and Idelalisib-Rituximab at Scripps Health…
Susan M. O’Brien, MD of University of California Irvine discusses the preferred frontline regimen for new CLL patients greater than…
Susan M. O’Brien, MD of University of California Irvine discusses how to decide between Ibrutinib and Idelalisib-Rituximab in relapse setting…
Susan M. O’Brien, MD of University of California Irvine discusses FCR produces better and longer progression free survival than BR…
Susan M. O’Brien, MD of University of California Irvine discusses Duvelisib and other PI3K inhibitors in CLL at Scripps Health…
Susan M. O’Brien, MD of University of California Irvine discusses Acalabrutinib, ONO-4059 and other novel BTK inhibitors in CLL at…
Omid Hamid, MD of The Angeles Clinic discusses the future of Immunotherapy new developments and new clinical trials at Scripps…
Omid Hamid, MD of The Angeles Clinic discusses how important it is in Immunotherapy to find the correct biomarkers at…
Omid Hamid, MD of The Angeles Clinic discusses immune related adverse events within melanoma and other disease states at Scripps…
At the German Cancer Congress 2016, held in Berlin, Germany from 24 February to 27 February 2016, Thomas Seufferlein, MD,…
Pancreatic cancer is a leading cause of cancer-related deaths in developed countries. At the German Cancer Congress 2016, held in…
At the German Cancer Congress 2016, held in Berlin, Germany from 24 February to 27 February 2016, Thomas Seufferlein, MD,…
Owen A O’Connor, MD, PhD from the Columbia University Medical Center Center for Lymphoid Malignancies, New York, NY, talks about…
Wyndham Wilson, MD, PhD from the National Cancer Institute, Bethesda, MD talks about the concept of precision medicine in lymphoid…
Wyndham Wilson, MD, PhD from the National Cancer Institute, Bethesda, MD talks about the new developments in the fields of…
Wyndham Wilson, MD, PhD from the National Cancer Institute, Bethesda, MD talks about drugs that have been developed to indirectly…
Owen A O’Connor, MD, PhD from the Columbia University Medical Center Center for Lymphoid Malignancies, New York, NY, talks about…
Owen A O’Connor, MD, PhD from the Columbia University Medical Center Center for Lymphoid Malignancies, New York, NY, discusses the…
Owen A O’Connor, MD, PhD from the Columbia University Medical Center Center for Lymphoid Malignancies, New York, NY, talks about…
Owen A O’Connor, MD, PhD from the Columbia University Medical Center Center for Lymphoid Malignancies, New York, NY, presents the…
Elias Jabbour, MD from the University of Texas MD Anderson Cancer Center, Houston, TX talks about the different forms of…
Elias Jabbour, MD from the University of Texas MD Anderson Cancer Center, Houston, TX talks about a Phase II clinical…
Gareth Morgan, MD, FRCP, FRCPath, PhD from the University of Arkansas for Medical Sciences, Arkansas, AR discusses some of the…
Gareth Morgan, MD, FRCP, FRCPath, PhD from the University of Arkansas for Medical Sciences, Arkansas, AR discusses the results of…
Anders Österborg, MD, PhD from the Karolinska Hospital & Institute, Stockholm in Sweden gives an overview of the data presented…
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December…
Recent advances in the understanding of the biology of thyroid cancer have led to the development of targeted therapies, such…
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December…
Morie A. Gertz, MD of Mayo Clinic discusses the indications for systemic therapy of Waldenstroms Macroglobulinemia at Scripps Health 36th…